Goldman Sachs Raises PT on Mindray Medical to $26.90

by Juan Lopez, Benzinga Staff Writer
January 10, 2012 5:53 AM | 8 seconds read | Make a Comment
Loading...
Loading...
Goldman Sachs has raised the price target on Mindray Medical
MR
from $24.50 to $26.90 and maintains its Neutral rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: Price TargetPre-Market OutlookAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!